Exploiting anthracycline scaffold for designing DNA-targeting agents

One possible approach to controlling the effects of pathogenic genes is to control their expression at the transcription level. However, only a small number of high-affinity DNA-binding agents are currently available, and their sequence selectivity is limited. Clearly, there is an urgent need to dev...

Ausführliche Beschreibung